Men at the Princess Margaret Cancer Center with low-risk prostate cancer at diagnosis (Gleason score <7, <4 positive cores, <50% involvement of any one core, and PSA <10.0 ng/dl), who had not undergone active treatment were eligible. This evidence concerns the gene KLK3 and prostate carcinoma.